Benzanilide–Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators

ACS Medicinal Chemistry Letters
2013.0

Abstract

Recently reported compounds such as UR-COP78 (6) are among the most potent and selective ABCG2 modulators known so far but are prone to rapid enzymatic cleavage at the central benzanilide moiety. In search for more stable analogues, according to a bioisosteric approach, a series of N-(biphenyl-3-yl)quinoline carboxamides was prepared by solid phase and solution phase synthesis. The biphenyl moiety was constructed by Suzuki coupling. Inhibition of ABCB1 and ABCG2 was determined in a calcein-AM and a Hoechst 33342 microplate assay, respectively. Most synthesized compounds selectively inhibited the ABCG2 transporter at submicromolar concentrations with a maximal inhibitory effect (I max) over 90% (e.g., UR-COP228 (22a), IC50 591 nM, I max 109%; UR-COP258 (31), IC50 544 nM, I max 112%), though with lower potency and selectivity than 6. The biphenyl analogues are considerably more stable and demonstrate that the benzanilide core is not a crucial structural feature of quinoline carboxamide-type ABCG2 modulators.

Knowledge Graph

Similar Paper

Benzanilide–Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators
ACS Medicinal Chemistry Letters 2013.0
Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)
Journal of Medicinal Chemistry 2016.0
Tariquidar-Related Chalcones and Ketones as ABCG2 Modulators
ACS Medicinal Chemistry Letters 2018.0
Phenyltetrazolyl-phenylamides: Substituent impact on modulation capability and selectivity toward the efflux protein ABCG2 and investigation of interaction with the transporter
European Journal of Medicinal Chemistry 2016.0
Synthesis and biological investigation of 2,4-substituted quinazolines as highly potent inhibitors of breast cancer resistance protein (ABCG2)
European Journal of Medicinal Chemistry 2017.0
Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP)
European Journal of Medicinal Chemistry 2020.0
The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2)
European Journal of Medicinal Chemistry 2016.0
Synthesis and biological evaluation of quinazoline derivatives – A SAR study of novel inhibitors of ABCG2
European Journal of Medicinal Chemistry 2019.0
4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2)
Journal of Medicinal Chemistry 2017.0
Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2)
Bioorganic & Medicinal Chemistry 2013.0